Deepa Prasad serves as an independent advisor to Équilibre Biopharmaceuticals Corp. and Graviton Biosciences and a strategic advisor to vTv Therapeutics (VTVT). Ms. Prasad most recently served as president/CEO and a board member of vTv. Prior to vTv, Ms. Prasad was managing director at WestRiver Group, where she led investments in healthcare innovation across biotech and digital health/AI. Ms. Prasad has held various healthcare operational roles as chief of staff at Blue Shield of California, regional vice president for Optum, head of managed care at the California Hospital Association, and vice president, financial strategy and business development at Coherus Biosciences (CHRS). She began her career in investment banking working with biotech and pharma companies on private placements and buyside and sellside mergers and acquisitions, including cross-border M&A with several Japanese pharma. She currently serves on the grant funding committee for UC Davis and as a charter member for TiE, a non-profit global network of entrepreneurs and venture capitalists. Ms. Prasad earned her bachelor’s degree in business administration at the University of California, Berkeley and her M.B.A. from the Kellogg School of Management at Northwestern University with emphasis in finance and health industry management.